Editor's Note The antibody shot Nirsevimab can protect infants from hospitalization from respiratory syncytial virus (RSV). The results from the new clinical trial were published December 28 in The New England Journal of Medicine. Affecting two of three children in their first year of life, RSV causes seasonal infection and,…

Read More

Editor’s note Moderna’s mRNA-based RSV vaccine is effective in preventing RSV-associated lower-respiratory tract disease in adults aged 60 an older, according to randomized phase II-III trial results published December 14 in The New England Journal of Medicine. Results also confirmed the safety of a single dose of the vaccine, researchers…

Read More

Editor's Note The Centers for Disease Control and Prevention (CDC) is sounding the alarm regarding low vaccination rates for COVID-19 and flu for all adults, as well as low RSV vaccination rates for adults 60 and older. According to the December 14 announcement, study data show anti-virals are also being…

Read More

Editor's Note Receiving a fourth dose of the COVID-19 mRNA vaccine recommended for patients with autoimmune rheumatic diseases, including rheumatoid arthritis, was found to have saved lives and reduced hospitalizations among that patient population. The findings were published in the journal The Lancet Rheumatology on November 15. The researchers used…

Read More

Editor's Note A new nasal vaccine in development by Griffith University’s Institute for Glycomics in Australia could provide long-term protection against the deadly bacteria Streptococcus A (Strep A), Griffith University's Griffith News October 5 reports. Strep A causes 700 million human infections each year, and there are more than 500,000…

Read More

Editor's Note A new study suggests that someone's initial exposure to a specific COVID-19 variant shows some influence to their immune response to subsequent variants of SARS-CoV-2, the virus responsible for COVID-19, the University of Cambridge October 6 reports. The research, published by Science on October 6 and titled "Mapping…

Read More

Editor's Note An experimental vaccine designed by researchers at University of Southern California has been shown to prevent serious infections from drug-resistant pathogens, according to an October 2023 study published by Science Translational Medicine. In this study, titled "A protein-free vaccine stimulates innate immunity and protects against nosocomial pathogens," the…

Read More

Editor's Note A new vaccine for respiratory syncytial virus (RSV) has been found to be effective against a range of variants, according to an August 2023 Science Translational Medicine research article titled, "The RSVPreF3-AS01 vaccine elicits broad neutralization of contemporary and antigenically distant respiratory syncytial virus strains." This research was…

Read More

Editor's Note With COVID-19 rates rising again, and winter cold and flu season around the corner, it is time for healthcare personnel to get a COVID-19 booster shot to help protect against illness–and recommend patients to do the same. In a September 2023 TIME Magazine article, doctors weigh in on…

Read More

Editor's Note JAMA Network published a research article on October 27 showing the long-term effects of COVID-19 on adults in the US and evaluating vaccine effectiveness for lasting symptoms, Health Leaders Media October 28 reports. The World Health Organization defines symptoms that last for at least 2 months post-infection as…

Read More